Literature DB >> 33667270

Genetic ablation of fibroblast activation protein alpha attenuates left ventricular dilation after myocardial infarction.

Daniel B Hoffmann1,2, Daniela Fraccarollo2, Paolo Galuppo2, Stefan Frantz3, Johann Bauersachs2, Jochen Tillmanns2.   

Abstract

INTRODUCTION: Regulating excessive activation of fibroblasts may be a promising target to optimize extracellular matrix deposition and myocardial stiffness. Fibroblast activation protein alpha (FAP) is upregulated in activated fibroblasts after myocardial infarction (MI), and alters fibroblast migration in vitro. We hypothesized that FAP depletion may have a protective effect on left ventricular (LV) remodeling after MI.
MATERIALS AND METHODS: We used the model of chronic MI in homozygous FAP deficient mice (FAP-KO, n = 51) and wild type mice (WT, n = 55) to analyze wound healing by monocyte and myofibroblast infiltration. Heart function and remodeling was studied by echocardiography, morphometric analyses including capillary density and myocyte size, collagen content and in vivo cell-proliferation. In non-operated healthy mice up to 6 months of age, morphometric analyses and collagen content was assessed (WT n = 10, FAP-KO n = 19).
RESULTS: Healthy FAP-deficient mice did not show changes in LV structure or differences in collagen content or cardiac morphology. Infarct size, survival and cardiac function were not different between FAP-KO and wildtype mice. FAP-KO animals showed less LV-dilation and a thicker scar, accompanied by a trend towards lower collagen content. Wound healing, assessed by infiltration with inflammatory cells and myofibroblasts were not different between groups.
CONCLUSION: We show that genetic ablation of FAP does not impair cardiac wound healing, and attenuates LV dilation after MI in mice. FAP seems dispensable for normal cardiac function and homeostasis.

Entities:  

Year:  2021        PMID: 33667270     DOI: 10.1371/journal.pone.0248196

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  2 in total

1.  A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al18F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease.

Authors:  Zhehao Lyu; Wei Han; Hongyue Zhao; Yuying Jiao; Peng Xu; Yangyang Wang; Qiuyi Shen; Shuai Yang; Changjiu Zhao; Lin Tian; Peng Fu
Journal:  Front Cardiovasc Med       Date:  2022-08-22

Review 2.  Immune Cells and Immunotherapy for Cardiac Injury and Repair.

Authors:  Joel G Rurik; Haig Aghajanian; Jonathan A Epstein
Journal:  Circ Res       Date:  2021-05-27       Impact factor: 23.213

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.